Decade in review--cardiomyopathies: Cardiomyopathy on the move

Magdi H Yacoub1

  • 1Qatar Cardiovascular Research Center, PO Box 5825, Doha, Qatar.

Insights

Cardiomyopathy research has advanced significantly over the last decade, increasing our understanding of these heart muscle diseases. This progress has begun to demystify the complexities of various cardiomyopathies for patients and medical professionals.

Area of Science:

  • Cardiology
  • Internal Medicine
  • Genetics

Background:

  • Cardiomyopathy, a term coined in 1952, encompasses a group of heart muscle diseases.
  • These conditions have consistently garnered significant attention from clinicians, researchers, and patients.
  • Despite historical interest, the underlying mechanisms of cardiomyopathies remain incompletely understood.

Purpose of the Study:

  • To review recent advancements in understanding various types of cardiomyopathies.
  • To highlight key discoveries that have improved diagnostic and therapeutic approaches.
  • To provide an updated perspective on the current state of cardiomyopathy research.

Main Methods:

  • Comprehensive literature review of studies published in the last decade.
  • Analysis of clinical trial data and genetic research findings.
  • Synthesis of information on epidemiological, etiological, and pathophysiological aspects.

Main Results:

  • A substantial body of new knowledge has emerged regarding diverse cardiomyopathies.
  • Significant progress has been made in identifying genetic underpinnings and molecular pathways.
  • Improved diagnostic tools and emerging therapeutic strategies have been developed.

Conclusions:

  • The past decade has markedly enhanced our comprehension of cardiomyopathies.
  • Ongoing research continues to unravel the complexities of these heart conditions.
  • This accumulated knowledge offers improved prospects for patient care and management.

Related Concept Videos

Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
809
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
767
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
930
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
795
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
743
Cardiomyopathy VI: Nursing Management01:29

Cardiomyopathy VI: Nursing Management

Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
476